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IgE Trimers Drive SPE-7 
Cytokinergic Activity
Heather J. Bax1,2, Holly Bowen1,2,3, Rebecca L. Beavil1,2, Raymond Chung4, Malcolm Ward4, 
Anna M. Davies1,2, Tihomir S. Dodev1,3, James M. McDonnell1,2, Andrew J. Beavil  1,2, Brian J. 
Sutton1,2 & Hannah J. Gould  1,2,3
Degranulation of mast cells and basophils, with release of agents of the allergic response, ensues 
when multivalent antigens bind to and cross-link the cells’ receptor-bound IgE antibodies. A widely 
used commercial monoclonal IgE antibody, SPE-7 IgE from Sigma, was found to possess the 
radically anomalous property, termed “cytokinergic”, of inducing basophil degranulation without 
the intervention of an antigen. We show here that the IgE monomer, freed of protein contaminants, 
is devoid of this activity, and that the source of the anomaly is a trace impurity, identified as a 
dissociation-resistant IgE trimer. Possible models for the formation of IgE trimers and the manner in 
which they cross-link cell surface receptors are suggested herein.
The function of IgE antibodies in adaptive immunity is to erect an effective barrier against infection by 
multi-cellular parasites and the toxicity of animal venoms1. These antibodies bind tightly to high-affinity recep-
tors (FcεRI) on mast cells in surface tissues, or on basophils in the blood, to sequester the parasite antigens or 
toxins and evoke an immediate and potent immune response. A central feature of this mechanism is cross-linking 
of the receptor by attachment of a multivalent antigen to two or more receptor-bound IgEs, thereby delivering the 
signal for mast cell or basophil activation2, 3. The cost of the evolution of this protective mechanism in mammals 
is the risk of sensitization to otherwise harmless antigens (allergens) with the development of allergic disease. IgE 
binding to the receptors in the absence of antigen should not induce cell activation, which would serve no pur-
pose in adaptive immunity, and could indeed pose a severe danger. The discovery of several monoclonal IgEs that 
stimulate mast cell and basophil activation without the need for an antigen was therefore perplexing4.
At the time of this discovery, it was already known that IgE at extremely high concentrations (5 μg/ml), some 
two orders of magnitude higher than that required for antigen-dependent cell activation, could up-regulate 
IgE receptor expression on mast cells5–7. Kitaura et al. further established that some monoclonal IgEs could 
induce cell activation in the absence of antigen. Different monoclonal IgEs could be classified according to their 
antigen-independent activities, for which they coined the term, “cytokinergic activity”4. The higher this cytokin-
ergic activity of the IgE, the greater the variety and potency of the activities it evoked. Monoclonal IgEs were 
grouped according to whether they were highly cytokinergic (HC), moderately (MC), or poorly (PC) so. Only 
IgEs in the first (HC) category could induce mast cell degranulation in the absence of allergen. The most highly 
cytokinergic IgE was the mouse NS1 hybridoma SPE-7 IgE, an anti-dinitrophenyl (DNP) antibody8, 9. At 5 μg/
ml the SPE-7 IgE alone activates mast cells and basophils to nearly the same extent as it does at 0.02 μg/ml in the 
presence of antigen, and by the same receptor cross-linking mechanism normally initiated by the antigen4.
In some cases, sufferers from allergic disease were found by Bennich and Johansson10 to have concentrations 
of circulating IgE of up to 5 μg/ml and it was therefore suggested that antigen-independent (“cytokinergic”) IgE 
action may play a part in the pathophysiology of allergic diseases4, 11, 12. The inhibition of cytokinergic activity by 
free DNP, and more recently by recombinant SPE-7 IgE Fab, pointed to the Fv domain as the seat of the cytokin-
ergic activity of the SPE-7 IgE antibody4, 13, 14.
In the present study, with the aid of higher resolution from a new size-exclusion column matrix, we show 
that SPE-7 IgE monomers are devoid of cytokinergic activity when isolated from all contaminants. This new 
technology has also enabled us to demonstrate the presence of a previously unrecognized component in SPE-7 
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IgE preparations: an SPE-7 IgE trimer that drives the cytokinergic activity. We thus resolve a long-standing issue 
concerning the nature of the cytokinergic phenomenon.
Results
To determine the origins of the exceptional cytokinergic action of SPE-7 IgE (Sigma), we isolated the pure 
monomeric IgE from the crude commercial product. For comparison we purified the equivalent monomeric 
IgE from the NS1 hybridoma (kindly provided by Dr. Zelig Eshhar) and recombinant SPE-7 produced in HEK 
cells using the sequence derived from the hybridoma. The recombinant SPE-7 was expressed both as wild-type 
mouse protein (mSPE-7) and as a mouse-human chimaeric form, comprising mouse SPE-7 IgE heavy- and 
light-chain variable regions and human constant regions (chSPE-7; Supplementary Figure 1). The monomers 
were isolated by size-exclusion chromatography on a Superdex 200 column and pooled fractions were assayed for 
antigen-independent activity in a rat basophil cell line expressing both the human and mouse high-affinity IgE 
receptors (RBL-SX38 cells). By contrast with the potent degranulating activity of the crude commercial product, 
none of our three purified proteins showed any detectable degranulating action (Fig. 1). At the same time, the four 
proteins became comparably active on addition of antigen (DNP coupled to human serum albumin, DNP-HSA). 
These results imply that the highly cytokinergic activity of SPE-7 may be due to a contaminating protein.
Examination of the SPE-7 product by SDS-PAGE revealed abundant contamination with other apparently 
unrelated proteins, amounting to 15–20% of the total protein (Supplementary Figure 2A). We were able to iden-
tify several of these components by their partial sequences obtained by LC-MS/MS, following tryptic digestion. 
By comparison with the sequences derived from NS1-hybridoma cells, bands 1 and 4 (Supplementary Figure 2B) 
were confirmed to be mSPE-7 IgE heavy- and light-chains respectively (Supplementary Figure 2C). The overall 
sequence coverage with the NS1-hybridoma cell-derived sequences was 68 and 89%, respectively. Contaminating 
bands 2, 3, 5 and 6 were also extracted and identified by LC-MS/MS to represent a range of extraneous proteins 
including mouse complement components C3 and C4 (Supplementary Figure 2B and Supplementary Table 1).
C3a has been reported to activate some mast cells15–20. Although, RBL cells are not thought to express com-
plement receptors21, 22, we assayed mouse C3a in the rat basophil system to exclude degranulating activity. 
Degranulation was not elicited by recombinant C3a nor by the active, though not cytokinergic, recombinant IgE 
combined with C3a (Supplementary Figure 2D). We could therefore exclude C3a as a source of activation by the 
crude SPE-7 IgE.
Proteins smaller than IgE also appeared in the size-exclusion elution profile (Fig. 2A). These proteins, when 
pooled and mixed with the inactive recombinant SPE-7 IgEs, were inert in the same assay and thus also failed to 
account for the apparent cytokinergic activity of the crude Sigma SPE-7 IgE (Fig. 2B).
This left the proteins larger than the IgE monomer to be considered. The size-exclusion chromatography elu-
tion profile of IgE from the Superdex 200 column (Figs 1A and 2A) displayed, in agreement with earlier work11, 13, 
unresolved material on the leading edge of the IgE monomer zone. To achieve higher resolution in this size range 
we took advantage of the newly introduced, Superdex 200 Increase column matrix (Fig. 3A). On this column, 
Sigma SPE-7 IgE monomer was preceded by two distinct components comprising 1.6% (peak A) and 5.9% (peak 
B) of the total protein. Basophil degranulation assays using these components demonstrated that component B 
had about 65% of the activity of the unpurified Sigma SPE-7 IgE and appreciably more than that of component A 
or the more highly purified monomeric (component C) (Fig. 3B). At the same time, these three proteins became 
active on addition of multimeric antigen (DNP-HSA; data not shown).
Some overlap between the peaks was observed, so the preparation was scaled up using culture supernatants 
from the NS1 hybridoma cell line (Fig. 4). Comparison of the separations achieved by the Superdex 200 and 
Superdex 200 Increase demonstrates the superior resolution of the latter (Fig. 4A). Molecular mass determina-
tion by size exclusion chromatography multi-angle laser light scattering (SEC-MALLS; Fig. 3B) determined a 
molecular mass of 4100 ± 123 kDa for the protein in peak A, 540 ± 49 kDa for B and 180 ± 2 kDa for C. Thus com-
ponent A appears to contain the IgE previously identified by others as an inactive aggregate11, 13. Component B 
contained trimers of IgE, which were partially resolved for the first time from the purified IgE monomers in peak 
C and the aggregate in peak A (Fig. 4B). The error in determining the molecular mass excluded the possibility of 
this component containing IgE dimers. SDS-PAGE analysis showed that the main components of the IgE trimer 
preparation, alongside the purified monomer and unpurified Sigma mSPE-7 IgE, corresponded to the IgE heavy 
and light chains (Supplementary Figure 3).
Peak A was, as expected on the basis of earlier work, inactive in the basophil degranulation assay (Fig. 4C). 
The IgE in peak C showed significantly diminished activity after purification (Fig. 4D). Nevertheless, both of these 
components became active on addition of multimeric antigen (DNP-HSA; data not shown). In contrast, the IgE 
in peak B exerted 55% of the unpurified Sigma SPE-7 IgE’s activity, and this activity was significantly greater than 
that of the IgE in peaks A and C (Fig. 4E and F). We conclude that the cytokinergic activity requires a previously 
unrecognised component of IgE trimer in the unfractionated Sigma SPE-7.
The above results leave no doubt that monomeric SPE-7 IgE has of itself no cytokinergic activity, or any doubt 
about the source of this activity in the Sigma IgE product, and most probably therefore in other monoclonal IgE 
preparations displaying cytokinergic activity at lower levels. The results nevertheless raise further questions, as 
discussed below.
Discussion
Reports that basophils or mast cells respond to high concentrations of certain monoclonal IgE antibodies date 
back to 19855. Sensitization with these IgE antibodies manifests itself as a rise in cell signalling, leading to 
up-regulation of the high-affinity IgE FcεRI surface receptors on mast cells and basophils, increased cell survival, 
and cytokine secretion. These all occur in varying degrees, depending on the antibody4, 9, 11. Kitaura et al. coined 
www.nature.com/scientificreports/
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Figure 1. SPE-7 IgE monomer is not cytokinergic. Monomeric IgE was isolated from (A) Sigma mSPE-7 
IgE (Sigma mSPE-7), (B) NS1 hybridoma cell mSPE-7 IgE (NS1 mSPE-7), and (C) recombinant mSPE-7 
and chSPE-7 IgE (Rec. mSPE-7 and Rec. chSPE-7) preparations by size-exclusion chromatography using the 
Superdex S200 HPLC column. Purification profiles (left panels) show selected monomeric fractions between 
dotted vertical lines. Incubation with unpurified Sigma mSPE-7 IgE in the absence of antigen resulted in 
significant RBL-SX38 degranulation compared to buffer background control in all experiments (right panels, 
black lower bars; ****P < 0.0001). Monomeric IgE from all preparations did not induce degranulation 
of RBL-SX38 cells compared to buffer background control (right panels, black lower bars; ns P > 0.05). 
Functionality of the monomeric IgE antibodies was confirmed by measurement of degranulation upon cross-
linking with multimeric antigen, DNP-HSA (right panels, upper white bars). Means of 3 or 4 independent 
experiments ± SEM are shown. Statistically significant difference to background control was determined by 
one-way ANOVA with Dunnett’s post-test.
www.nature.com/scientificreports/
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the term “cytokinergic” for this erratic phenomenon, and classified the responsible IgEs according to the magni-
tude of the response as high (HC), moderate (MC) or poor (PC)4.
A single antibody preparation, the commercial mouse hybridoma SPE-7 anti-DNP IgE from Sigma, stands at 
the high-response extreme of the HC group, and causes not only pre-sensitization to antigen activation, but also 
degranulation of basophils and mast cells in the absence of antigen4, 13. This was not observed in the earlier study 
with this antibody11, but was confirmed in subsequent published work14, 23–28, and also here. The reason for this 
discrepancy has not been resolved.
This highly cytokinergic activity was confined to a small sub-group of the monoclonal IgEs, but it appears 
to violate a tenet of cellular immunology, that cell activation is initiated by cross-linking and clustering of, in 
this case, IgE-bearing surface receptors on binding of multivalent antigens. This raises the question of how such 
cross-linking might occur without intervention of a divalent or multivalent antigen.
Figure 2. Small protein contaminants in the Sigma mSPE-7 IgE preparation are not responsible for its 
cytokinergic activity. (A) Analysis of the unpurified Sigma mSPE-7 IgE preparation by size-exclusion 
chromatography using the Superdex S200 HPLC column revealed the presence of small protein contaminants. 
Fractions smaller than monomeric IgE (fractions 1) were collected and pooled as small contaminants (fractions 
2, also magnified in inset). (B) Although unpurified Sigma mSPE-7 IgE, in the absence of antigen, resulted in 
significant RBL-SX38 degranulation compared to buffer background control (black lower bar; ****P < 0.0001), 
the contaminants alone or in combination with 5 μg/ml recombinant SPE-7 IgE monomer, did not exhibit any 
cytokinergic activity (black lower bars; ns P > 0.05). Means of 3 independent experiments ± SEM are shown. 
Statistically significant difference to background control was determined by one-way ANOVA with Dunnett’s 
post-test.
Figure 3. Improved size-exclusion chromatography resolves a previously unrecognized component in 
mSPE-7 IgE that has cytokinergic activity. (A) The superior resolution of SPE-7 IgE by Superdex 200 Increase 
compared to Superdex 200, resolved a component of intermediate size (Peak B) between the monomer (Peak 
C) and aggregated SPE-7 IgE (Peak A). (B) Low levels of degranulation were induced by components A and C, 
compared to component B. Means of triplicate technical repeats ± SEM are shown.
www.nature.com/scientificreports/
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One plausible explanation was implicit in the results of Kalesnikoff et al. and Kitaura et al.4, 11, namely, the 
existence of a secondary (weak) IgE binding site in the Fab arms of the receptor-bound SPE-7 IgE. This would 
capture a free, unbound IgE from the supernatant that could attach itself to receptor-bound IgEs so as to form a 
Figure 4. mSPE-7 IgE trimer displays cytokinergic activity. (A) Improved size fractionation of mSPE-7 IgE 
was achieved with a Superdex 200 Increase HPLC column. (B) SEC-MALLS analysis of peaks A, B and C from 
the column determined the percentage of high molecular weight aggregates, trimers and monomers in Peaks 
A, B and C, respectively. The percentages of each in the three fractions are indicated. (C) No RBL-SX38 cell 
degranulation above buffer background control was induced by incubation with the IgE in peak A preparation 
(65.6% aggregated IgE), in the absence of antigen. (D) Significant, but low-level degranulation, compared to 
buffer background control was induced by incubation with 5 μg/ml of the IgE in peak C (95.1% monomeric IgE 
and 4.1% trimeric IgE) in the absence of antigen. Incubation with unpurified Sigma mSPE-7 IgE, in absence 
of antigen, resulted in significant RBL-SX38 degranulation compared to buffer background control in both 
experiments. (E) Significant RBL-SX38 cell degranulation was induced by incubation with NS1 mSPE-7 IgE 
trimer in the absence of antigen (peak B in purification profile). (F) Degranulation induced by peaks A, B 
and C at 5 μg/ml is compared. Means of 3 independent experiments ± SEM are shown. Statistically significant 
difference to background control (unless otherwise indicated) was determined by one-way ANOVA with 
Dunnett’s post-test; ****P < 0.0001, **P = 0.001 to 0.01, ns P > 0.05.
www.nature.com/scientificreports/
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cross-link, thereby simulating the action of a divalent antigen. In support of this scheme is the rapid termination 
of the HC activity by (1) removal of free SPE-7 IgE from the medium13, 29, or (2) addition of monovalent DNP 
hapten or recombinant SPE-7 IgE Fab13, 14. Furthermore, we have shown that the postulated cross-linking occurs 
through an Fv/Fv interaction14. These features are strongly reminiscent of an idiotype-anti-idiotype (Id-anti-Id) 
reaction. Intriguingly, SPE-7 IgE has been shown to display multi-specificity, binding not only to DNP, but also to 
a totally unrelated protein antigen30, 31. The ‘conformationally labile’ CDRs may be responsible for the occurrence 
of this Fv/Fv (protein-protein) interaction.
A mechanism by which the exceptionally high expression of the FcεRI-bound monoclonal IgE might 
enhance even a low affinity interaction between the free and bound IgE was proposed32. The authors envisaged 
an un-physiological situation in which a self-reactive monoclonal IgE, saturating the receptor binding sites on 
the cell surface, are exposed to a large excess of the same IgE. Self-association between the free and bound IgEs 
would be strongly enhanced by the large number (5 × 105) of the receptors and the mobility of the IgE-receptor 
complexes on the cell surface.
Attempts in previous studies to free the SPE-7 IgE monomer of all traces of oligomers, which upon binding 
to the surface receptors could cause FcεRI clustering, were evidently insufficient to eliminate the trimers that we 
have now separated by affinity chromatography followed by a superior size-exclusion chromatography matrix 
(Fig. 4A).
The primary outcome of the results presented here is that the IgE monomer in the widely used SPE-7 Sigma 
product has no detectable cytokinergic activity. It would not be surprising if the same conclusion were, by exten-
sion, equally true for other monoclonal IgE preparations falling into the HC class. Our results further suggest that 
the outcome of earlier work on supposedly cytokinergic IgE preparations may have been vitiated by inadequate 
resolving power of the methods available at the time and may need to be re-evaluated.
The conclusion that a trimer is responsible for the degranulating action of the SPE-7 IgE preparation raised 
a number of new questions. We may ask in the first place why the trimer is the only IgE oligomer that is formed. 
A linear self-association process would lead to dimers, trimers and higher forms in predictable proportions, 
depending on the subunit concentration, as seen for example in negative-stain electron microscopy (EM) of 
antigen-IgE complexes33. However, in this recent study, as also in earlier EM investigations of self-associating 
(Id-anti-Id) or cross-linked (by divalent haptens) IgG34–37 or IgE molecules38, a preponderance of cyclic dimers, 
trimers or tetramers, rather than linear complexes, was observed. A feature of the IgG structure, missing in IgE, 
is the presence of a flexible “hinge” between the Fab and Fc regions; this allows the angle between the Fab arms 
to vary widely, permitting formation of a range of cyclic structures. However, the more restricted flexibility of 
IgE, lacking a hinge region, might be expected to limit the possible oligomers that can form. Cyclic oligomers are 
thermodynamically favoured provided that the structures are not strained in ring formation.
A further key factor is the location of the epitope recognised by the self-associating antibody; in the study by 
Gieras et al.33, the relative disposition of epitopes presented on a model antigen dictated the types of complexes 
formed, including ring dimers or tetramers of IgE depending on the antigen. In the earlier Id-anti-Id study38, ring 
dimers and tetramers were again formed, although these consisted, respectively, of 1:1 and 2:2 complexes of IgE 
(Id-bearing) and IgG1 (anti-Id) antibodies. These studies indicate that IgE molecules alone can accommodate 
the formation of cyclic dimers or tetramers, and thus presumably also trimers, depending on the location and 
orientation of the epitope.
We have previously modelled the IgE Fab arms relative to the known structures of both free and 
receptor-bound IgE-Fc39, 40 and found that they are more restricted in their conformations than the more flexi-
ble IgG Fab arms. Furthermore, the range of inter-Fab angles in the models agrees well with the measured EM 
images: 141° ± 34° 38. Thus we can infer that SPE-7 IgE trimer formation involves each antigen-binding site rec-
ognising a determinant that we have shown is located within the Fv region14; the precise location of the epitope 
and the restricted flexibility of the SPE-7 IgE Fab arms may confine self-association to trimers alone. The ther-
modynamic stability of a cyclic structure, as observed in the earlier EM studies, is apparently sufficient to survive 
dilution during chromatography.
While we have shown that the antigen-independent degranulating activity of SPE-7 resides in the trimer frac-
tion, we cannot distinguish whether the trimers act directly upon the mast cells or interact with receptor-bound 
SPE-7 IgE monomers. This cannot be addressed experimentally since we have so far been unable to eliminate 
residual monomers from our trimer preparation. In any case, without knowing the precise structure of the trimer, 
it is impossible to predict whether the three SPE-7 IgE-Fc regions could engage three receptors simultaneously 
and lead to cell activation. In the unfractionated commercial SPE-7 samples, monomer predominates and must 
saturate the receptors, so that for the trimers to engage with receptor-bound monomer, we must assume that a 
cyclic trimer is capable of dissociation into an open structure.
We are confronted next with the problem of the circumstances under which the trimers are formed. Local 
concentration must be assumed to play a part. The SPE-7 IgE is a mouse hybridoma, and is synthesized in mouse 
ascites cells or in tissue culture, where the concentrations may favour self-association of the IgE. There may be 
other features of the manipulations that the preparations undergo during synthesis, purification, concentration, 
freezing and storage.
A final question is whether IgE trimers exist in vivo. Advocates of cytokinergic IgE have pointed out that the 
concentrations required for SPE-7 to provoke basophil degranulation may be reached in individuals infected by 
certain parasites or suffering from allergic disease. However, as previously pointed out32, HC IgE activity was dis-
covered in experiments with monoclonal IgEs. Situations in which IgE antibodies of a single specificity are gener-
ated at high concentrations must be quite rare, perhaps confined to monoclonal responses in germinal centre-like 
structures in tissues. Nevertheless, it has been shown that certain monoclonal IgE antibodies, notably SPE-7, can 
elicit antigen-independent mast cell activation in the skin of mice during sensitization to chemical haptens41.
www.nature.com/scientificreports/
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The cell degranulating action of SPE-7 IgE observed here conforms to the original definition of cytokinergic 
IgE insofar as it is antigen (DNP)-independent, yet it seems to involve self-association in the manner of a trimeric 
Id-anti-Id complex, rather than being an activity of monomeric IgE molecules.
Methods
SPE-7 cDNA synthesis and sequencing. RNA was extracted from SPE-7 IgE hybridoma cells (NS1 cells; 
kindly provided by Prof. Zelig Eshhar8), and the immunoglobulin heavy and light chains for SPE-7 IgE were 
amplified from hybridoma cDNA by PCR as previously described14. The variable region sequences are deposited 
in GenBank (Accession nos. KJ734989 and KJ734990).
Recombinant SPE-7 IgE PIPE cloning and expression. Polymerase incomplete primer extension 
(PIPE) cloning42 was used as previously described14, 43 to clone murine and chimeric SPE-7 IgE antibodies into 
pVITRO1 vector plasmids (Invivogen).
Human embryonic kidney cells (HEK293-F suspension FreeStyle™ cells; Invitrogen) were transfected with 
purified plasmid DNA using PEI (Sigma-Aldrich) and cultured in Dulbecco’s Modified Eagle medium (DMEM), 
supplemented with 10% FCS, 2 mmol/L L-glutamine, 10 U penicillin/streptomycin (all Invitrogen) at 37 °C and 
5% CO2. Following selection with 50 ng/ml hygromycin B (Invitrogen), cells were cultured in FreeStyle™ 293 
expression media (Invitrogen), supplemented with hygromycin B, in spinner culture flasks. Culture supernatants 
were harvested and filtered through a 0.45 μm cellulose acetate filter.
ELISA for detection of recombinant murine and human SPE-7 IgE expression and DNP spec-
ificity. Recombinant murine and chimaeric SPE-7 IgE (rmSPE-7 and rchSPE-7) protein expression and 
DNP-specificity was confirmed using ELISA plates (Maxisorp; Nunc) coated overnight with 5 mg/ml DNP-HSA 
(Sigma-Aldrich), blocked with PBS-1% BSA, and incubated with cell-free culture supernatants for 2 hours. This 
was followed by addition of HRP-conjugated anti-human IgE detection antibody diluted 1/5000 (Sigma), or 
anti-mouse IgE detection antibody diluted 1/2000, and then avidin-HRP diluted 1/1000 (both R&D Systems). 
IgE was detected with TMB (R&D Systems) by measuring absorbance at 450 nm.
SPE-7 IgE from the NS1 hybridoma cell lines. SPE-7 IgE hybridoma cells (NS1 cells; kindly provided 
by Prof. Zelig Eshhar8, were cultured in spinner culture flasks in Dulbecco’s Modified Eagle medium (DMEM), 
supplemented with 15% heat inactivated horse serum, 2 mmol/L L-glutamine, 10 U penicillin/streptomycin (all 
Invitrogen). Culture supernatants were harvested and filtered through a 0.45 μm cellulose acetate filter.
Purification of the monomeric and oligomeric SPE-7 IgE antibody and contaminating pro-
teins. The recombinant mSPE-7 and chSPE-7 IgE antibodies, and mSPE-7 IgE from the NS1 hybridoma cul-
ture were isolated from cell culture supernatants using an HiTrap NHS-activated HP column (GE Healthcare) 
amine coupled with IgG4-Fc(sFcεRIα)2 fusion protein44 and eluted with 0.2 M glycine, pH 2.5, before immediate 
neutralization with 1 M Tris, pH 8.6. Monomeric IgE antibodies were isolated by size-exclusion chromatography 
using a Superdex™ 200 column (Amersham Pharmacia Biotech) on an HPLC system (Gilson). For the designated 
experiments, the same purification methods (affinity chromatography and size exclusion) were used to purify the 
commercially available Sigma SPE-7 IgE and smaller contaminating proteins. Monomeric IgE antibodies were 
eluted at around 15 minutes and the contaminants were eluted after 20 minutes.
A new technology, the Superdex™ 200 Increase column (Amersham Pharmacia Biotech) was also utilized on 
the HPLC system (Gilson) to fractionate SPE-7 IgE produced from the NS1 hybridoma cell culture, which had 
first been isolated by means of the Fc(sFcεRIα)2 fusion protein, and the commercially available Sigma SPE-7 IgE.
SDS-PAGE and liquid chromatography tandem mass spectrometry (LC-MS/MS). SDS-PAGE 
electrophoresis was performed in 3-(N-morpholino) propane sulfonic acid (MOPS) buffer (Novex, Life 
Technologies) at 180 V for approximately 90 minutes. The gel was fixed and stained with Brilliant Blue G Colloidal 
stain (Sigma), and then de-stained to reduce background staining before a scanned image was recorded.
In-gel reduction, alkylation of cysteines and proteolytic digestion with trypsin (Promega) were performed 
on excised gel sections prior to liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis using a 
Thermo Scientific Orbitrap Velos Pro™ mass spectrometer coupled to a Proxeon EASY-nLC II nano-flow liquid 
chromatography system. Eluting peptides were ionised by electrospray ionisation. Precursor ions were surveyed 
between m/z 350–1800 at a resolution of 30000 and the twenty most intense ions were subjected to MS/MS by 
collision-induced fragmentation in the iontrap with a normalised collision energy value of 35.
Raw data from the mass spectrometry analysis were processed using Proteome Discoverer™ software, version 
1.4 with Mascot version 2.2 as the search algorithm. Initially, the data from gel bands 1–6 were searched against 
the uniprot_sprot_130220 database specifying mouse proteins (16597 entries). Then the data from selected 
gel bands, namely 1 and 4 only, was searched against an in-house custom database (128 entries), comprising 
sequences for SPE-7 IgE heavy chains and light chains derived from NS1-hybridoma cells. Finally, all database 
search results were reviewed within Scaffold 4.3.2 (Proteome Software) where protein identifications resulting 
from both the mouse protein database search and matches against the specific heavy and light chain SPE-7 IgE 
sequences, were filtered using a 95% confidence score and a minimum of three matched peptides to generate the 
overall protein sequence coverage.
SEC-MALLS. The three peaks isolated from the S200 Increase HPLC purification of NS1 mSPE-7 IgE were 
run again on the Superdex™ 200 Increase column (Amersham Pharmacia Biotech) to determine their molecular 
weight, using an inline miniDAWN light-scattering detector and an Optilab DSP Interferometric Refractometer, 
and the data was analysed using the ASTRA 4.9 software (Wyatt Technology).
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Mast cell activation assays. RBL-SX38 cells, which express both the native rat FcεRI and the human 
tetrameric form of FcεRI (kindly provided by Prof. Jean-Pierre Kinet45), were cultured in RPMI supplemented 
with 10% FCS, 2 mmol/L L-glutamine, 10 U of penicillin/streptomycin, and 50 μg/mL Geneticin (all Invitrogen) 
at 37 °C, 5% CO2. Cells were seeded at 1 × 104 cells/100 μl/well in a 96-well plate in complete media omitting 
Geneticin and cultured at 37 °C, 5% CO2 overnight before stimulation.
Following washing with HBSS/1% BSA, adherent cells were stimulated with IgE antibodies (diluted in 
HBSS/1% BSA to 5 μg/ml in 100 μl/well, unless otherwise stated) for 4 hours at 37 °C, 5% CO2. Sigma SPE-7 IgE 
was used directly from the vial (Sigma mSPE-7) or following HPLC chromatography. Cross-linking of IgE-bound 
FcεRI was carried out by incubation with 0.1 μg/ml DNP-HSA diluted in HBSS/1% BSA (Sigma-Aldrich) for 
1 hour at 37 °C, 5% CO2. Alternatively, mast cells were stimulated with up to 5 μg/ml recombinant murine C3a 
(Bio-Techne) alone or in combination with recombinant SPE-7 IgE.
After each incubation, supernatants were harvested for analysis. Cells were finally lysed with 100 μl/
well HBSS/0.5% Triton X-100 (Sigma-Aldrich) for 30 minutes at 37 °C, 5% CO2 and the lysates collected. 
β-hexosaminidase release was measured using 4-methylumbelliferyl N-acetyl-β-D-glucosaminide substrate 
(Sigma-Aldrich) as previously described46 and degranulation expressed as a percentage of the total for each well. 
Statistically significant difference between experimental conditions was determined by one-way ANOVA with 
Dunnett’s or Tukey’s post-test. GraphPad Prism (GraphPad Software, Inc.) was used for all statistical analyses.
Data Availability Statement. All data generated or analysed during this study are included in this pub-
lished article (and its Supplementary Information files).
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